Sana Biotechnology, Inc. - 8-K Filing
Sana Biotechnology reports Q3 2026 results with $121.7 million cash position and expected runway into mid-2027 (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $SANA
Read the full article at SEC EDGAR
Part of the story Crescent Capital BDC Reports Q3 2026 Earnings with Increased Net Investment Income (48 articles)